Sustained response to intrathecal rituximab in EBV associated Post-transplant lymphoproliferative disease confined to the central nervous system following haematopoietic stem cell transplant. [electronic resource]
Producer: 20120228Description: 459-61 p. digitalISSN:- 1545-5017
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Central Nervous System Diseases -- drug therapy
- Child, Preschool
- Epstein-Barr Virus Infections -- drug therapy
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Injections, Spinal
- Leukemia, B-Cell -- drug therapy
- Lymphohistiocytosis, Hemophagocytic -- drug therapy
- Lymphoproliferative Disorders -- drug therapy
- Magnetic Resonance Imaging
- Male
- Rituximab
- Virus Activation
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.